Literature DB >> 20848253

Integrating functional MRI information into radiotherapy planning of CNS tumors-early experiences.

Arpád Kovács1, Lilla Tóth, Csaba Glavák, Ferenc Lakosi, Janaki Hadjiev, Gábor Bajzik, Csaba Vandulek, Imre Repa.   

Abstract

The purpose of our study was to examine the integration of functional MRI (fMRI) information into 3D based planning process of the central nervous system (CNS) malignancies. Between 01.01.2008 and 01.12.2008 four patients with astrocytoma were enrolled to this study. Before the planning process conventional planning CT, postoperative MR and individual functional MRI examinations were delivered. For the functional MRI examination the following four types of stimulus were applied: acoustic, visual, somatosensory and numeral. Three different theoretical planning situations were applied and compared: 3D conformal plan without fMRI information, 3D conformal plan with fMRI information and IMRT plan with fMRI information. For plan comparison DVH analysis, and NTCP model were used. fMRI based OR definition resulted in 4 additional OR's in the contouring process. As these cases demonstrate, an average of 50% dose reduction was achieved in OR, OR2 and OR3 with IMRT and fMRI based 3D planning, especially in case of midline localization and big tumor extent. IMRT provides additional sparing effect in the optic tract and brainstem, especially for localizations close to the midline. Our results demonstrated that using fMRI information in conventional 3D based treatment planning potentially benefits significant dose reduction in critical organs, with no compromise in PTV coverage. fMRI can be widely used even in low grade cases (long life expectancies, lower acute and late toxicity in radiotherapy) and in cases with high grade astrocytomas or metastases (higher dose to PTV with better risk organ sparing in radiotherapy).

Entities:  

Mesh:

Year:  2010        PMID: 20848253     DOI: 10.1007/s12253-010-9298-y

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  17 in total

1.  Development of a model to predict permanent symptomatic postradiosurgery injury for arteriovenous malformation patients. Arteriovenous Malformation Radiosurgery Study Group.

Authors:  J C Flickinger; D Kondziolka; L D Lunsford; A Kassam; L K Phuong; R Liscak; B Pollock
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-03-15       Impact factor: 7.038

2.  The integral biologically effective dose to predict brain stem toxicity of hypofractionated stereotactic radiotherapy.

Authors:  B G Clark; L Souhami; C Pla; A S Al-Amro; J P Bahary; J G Villemure; J L Caron; A Olivier; E B Podgorsak
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-02-01       Impact factor: 7.038

3.  Risk analysis of linear accelerator radiosurgery.

Authors:  J Voges; H Treuer; V Sturm; C Büchner; R Lehrke; M Kocher; S Staar; J Kuchta; R P Müller
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-12-01       Impact factor: 7.038

4.  Cancer statistics, 2005.

Authors:  Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

5.  Functional magnetic resonance imaging aided radiation treatment planning.

Authors:  W C Liu; M Schulder; V Narra; A J Kalnin; C Cathcart; A Jacobs; G Lange; A I Holodny
Journal:  Med Phys       Date:  2000-07       Impact factor: 4.071

Review 6.  Paclitaxel pharmacology and other tumor types.

Authors:  E K Rowinsky
Journal:  Semin Oncol       Date:  1997-12       Impact factor: 4.929

7.  Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: a quantitative dosimetric study.

Authors:  S W Lee; B A Fraass; L H Marsh; K Herbort; S S Gebarski; M K Martel; E H Radany; A S Lichter; H M Sandler
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-01-01       Impact factor: 7.038

8.  Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial.

Authors:  M D Walker; E Alexander; W E Hunt; C S MacCarty; M S Mahaley; J Mealey; H A Norrell; G Owens; J Ransohoff; C B Wilson; E A Gehan; T A Strike
Journal:  J Neurosurg       Date:  1978-09       Impact factor: 5.115

9.  Intensity modulated radiotherapy (IMRT) decreases treatment-related morbidity and potentially enhances tumor control.

Authors:  Bin S Teh; Wei-Yuan Mai; Walter H Grant; J Kam Chiu; Hsin H Lu; L Steven Carpenter; Shiao Y Woo; E Brian Butler
Journal:  Cancer Invest       Date:  2002       Impact factor: 2.176

10.  Combined modality approach to treatment of malignant gliomas--re-evaluation of RTOG 7401/ECOG 1374 with long-term follow-up: a joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group.

Authors:  D F Nelson; M Diener-West; J Horton; C H Chang; D Schoenfeld; J S Nelson
Journal:  NCI Monogr       Date:  1988
View more
  5 in total

Review 1.  The evolution of imaging in cancer: current state and future challenges.

Authors:  Luke J Higgins; Martin G Pomper
Journal:  Semin Oncol       Date:  2011-02       Impact factor: 4.929

2.  Integrating functional MRI information into conventional 3D radiotherapy planning of CNS tumors. Is it worth it?

Authors:  Arpád Kovács; Lilla Tóth; Csaba Glavák; Gábor Liposits; Janaki Hadjiev; Gergely Antal; Miklós Emri; Csaba Vandulek; Imre Repa
Journal:  J Neurooncol       Date:  2011-07-02       Impact factor: 4.130

3.  Changes in functional MRI signals after 3D based radiotherapy of glioblastoma multiforme.

Authors:  Árpád Kovács; Miklós Emri; Gábor Opposits; Tamás Pisák; Csaba Vandulek; Csaba Glavák; Zoltán Szalai; Gergely Biró; Gábor Bajzik; Imre Repa
Journal:  J Neurooncol       Date:  2015-08-19       Impact factor: 4.130

Review 4.  Functional imaging in adult and paediatric brain tumours.

Authors:  Andrew C Peet; Theodoros N Arvanitis; Martin O Leach; Adam D Waldman
Journal:  Nat Rev Clin Oncol       Date:  2012-11-13       Impact factor: 66.675

5.  Radiotherapy planning using MRI.

Authors:  Maria A Schmidt; Geoffrey S Payne
Journal:  Phys Med Biol       Date:  2015-10-28       Impact factor: 3.609

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.